Vaccine Overview
Rubella Vaccine (Live) I.P. (Freeze-dried)
The Rubella Vaccine (Live) I.P. (Freeze-dried) is a vaccine used to protect against rubella, a contagious viral infection. It contains live, attenuated rubella virus and is administered via subcutaneous injection, typically in the upper arm. The vaccine is commonly given in combination with measles and mumps vaccines (MMR). The first dose is recommended at 9–12 months, with a second dose at 15–18 months. It helps prevent rubella-related birth defects if administered before pregnancy.
Drug Class: Viral Vaccines
Indication: For active immunization against rubella; For immunization of susceptible non-pregnant females of childbearing age; For immunization of adolescents and adult males for preventing or controlling outbreaks of rubella
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
First dose at 9–12 months, second dose at 15–18 months
Administration
Route: Subcutaneous injection
Site: upper outer part of the arm
Disease
Rubella
Manufacturer
Serum Intitute Of India
Age
- 9-18 months
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025